Reprogramming Metabolism by Targeting UCP2 Halts Leukemia Progression
Acute myeloid leukemia (AML) remains one of the most challenging hematological malignancies, notorious for its aggressive clinical course and frequent relapse after conventional chemotherapy. This...
















